scPharmaceuticals Reports Variability in Shelf-Life Testing for SCP-111 Combination Product
On December 11, 2024, scPharmaceuticals Inc. shared in an 8-K filing that it has encountered variability in shelf-life testing within one lot of the SCP-111 Combination Product. While the potential impact on the Company’s planned submission of the sNDA in January 2025 remains uncertain currently, there is a possibility that the submission might be delayed […]
More Stories
Colgate-Palmolive Announces Quarterly Dividend of $0.50 (NYSE:CL)
Colgate-Palmolive (NYSE:CL – Get Free Report) declared a quarterly dividend on Wednesday, December 11th,RTT News reports. Investors of record on...
Capricorn Energy (LON:CNE) Sets New 12-Month High – Here’s Why
Shares of Capricorn Energy PLC (LON:CNE – Get Free Report) hit a new 52-week high on Monday . The company...
Alaris Equity Partners Income Trust (AD.UN) (TSE:AD.UN) Senior Officer Matthew Mcintyre Sells 5,419 Shares
Alaris Equity Partners Income Trust (AD.UN) (TSE:AD.UN – Get Free Report) Senior Officer Matthew Mcintyre sold 5,419 shares of Alaris...
Liberty Broadband (NASDAQ:LBRDA) Shares Down 6.2% – Here’s Why
Liberty Broadband Co. (NASDAQ:LBRDA – Get Free Report) traded down 6.2% during trading on Monday . The stock traded as...
Creo Medical Group (LON:CREO) Sets New 1-Year Low – What’s Next?
Creo Medical Group PLC (LON:CREO – Get Free Report)’s share price hit a new 52-week low during mid-day trading on...
LIXIL Co. (OTCMKTS:JSGRY) Sees Large Growth in Short Interest
LIXIL Co. (OTCMKTS:JSGRY – Get Free Report) saw a large increase in short interest during the month of November. As...